Michel Sadelain, one of the fathers of CAR-T, the promising therapies against cancer: "They are living medications that multiply within the patient's body"
Michel Sadelain, a key figure in CAR-T therapy, discusses the advancements in cancer treatment and the ongoing challenges in targeting solid tumors.
Trained defenses attack the 'castle' of solid tumors: CAR-T therapies find weaknesses in the kidney, ovary, and pancreas
Recent advances in CAR-T therapy show potential for effectively targeting solid tumors in organs such as the kidney, ovary, and pancreas, addressing a significant challenge in cancer treatment.
Cancer: Argentina approves an immunotherapy for solid tumors that is administered through injections
Argentina's ANMAT has approved a new anti-PD-1 immunotherapy that can be administered via injections in three to five minutes, maintaining the efficacy of intravenous delivery.